2018-2023 Global Hospital Acquired Pneumonia Drugs Consumption Market Report

October 2018 | 136 pages | ID: 204E3CE0D0DEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Hospital Acquired Pneumonia Drugs market for 2018-2023.
Hospital-acquired pneumonia (HAP) or nosocomial pneumonia refers to any pneumonia contracted by a patient in a hospital at least 48–72 hours after being admitted. It is thus distinguished from community-acquired pneumonia. It is usually caused by a bacterial infection, rather than a virus.

Over the next five years, LPI(LP Information) projects that Hospital Acquired Pneumonia Drugs will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Hospital Acquired Pneumonia Drugs market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

• Phase II
• Early Phase (Phase I & II)

Segmentation by application:

• Hospital Pharmacies
• Retail Pharmacies
• Drug Store
• E-Commerce

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

• Basilea Pharmaceutica
• Meiji Holdings
• Cubist Pharmaceutical
• Aridis Pharmaceutical
• Valneva
• Bayer
• GlaxoSmithKline
• Merck
• Achaogen
• AstraZeneca

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

RESEARCH OBJECTIVES

• To study and analyze the global Hospital Acquired Pneumonia Drugs consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Hospital Acquired Pneumonia Drugs market by identifying its various subsegments.
• Focuses on the key global Hospital Acquired Pneumonia Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Hospital Acquired Pneumonia Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Hospital Acquired Pneumonia Drugs submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

2018-2023 GLOBAL HOSPITAL ACQUIRED PNEUMONIA DRUGS CONSUMPTION MARKET REPORT

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Hospital Acquired Pneumonia Drugs Consumption 2013-2023
  2.1.2 Hospital Acquired Pneumonia Drugs Consumption CAGR by Region
2.2 Hospital Acquired Pneumonia Drugs Segment by Type
  2.2.1 Phase II
  2.2.2 Early Phase (Phase I & II)
2.3 Hospital Acquired Pneumonia Drugs Consumption by Type
  2.3.1 Global Hospital Acquired Pneumonia Drugs Consumption Market Share by Type (2013-2018)
  2.3.2 Global Hospital Acquired Pneumonia Drugs Revenue and Market Share by Type (2013-2018)
  2.3.3 Global Hospital Acquired Pneumonia Drugs Sale Price by Type (2013-2018)
2.4 Hospital Acquired Pneumonia Drugs Segment by Application
  2.4.1 Hospital Pharmacies
  2.4.2 Retail Pharmacies
  2.4.3 Drug Store
  2.4.4 E-Commerce
2.5 Hospital Acquired Pneumonia Drugs Consumption by Application
  2.5.1 Global Hospital Acquired Pneumonia Drugs Consumption Market Share by Application (2013-2018)
  2.5.2 Global Hospital Acquired Pneumonia Drugs Value and Market Share by Application (2013-2018)
  2.5.3 Global Hospital Acquired Pneumonia Drugs Sale Price by Application (2013-2018)

3 GLOBAL HOSPITAL ACQUIRED PNEUMONIA DRUGS BY PLAYERS

3.1 Global Hospital Acquired Pneumonia Drugs Sales Market Share by Players
  3.1.1 Global Hospital Acquired Pneumonia Drugs Sales by Players (2016-2018)
  3.1.2 Global Hospital Acquired Pneumonia Drugs Sales Market Share by Players (2016-2018)
3.2 Global Hospital Acquired Pneumonia Drugs Revenue Market Share by Players
  3.2.1 Global Hospital Acquired Pneumonia Drugs Revenue by Players (2016-2018)
  3.2.2 Global Hospital Acquired Pneumonia Drugs Revenue Market Share by Players (2016-2018)
3.3 Global Hospital Acquired Pneumonia Drugs Sale Price by Players
3.4 Global Hospital Acquired Pneumonia Drugs Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global Hospital Acquired Pneumonia Drugs Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players Hospital Acquired Pneumonia Drugs Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 HOSPITAL ACQUIRED PNEUMONIA DRUGS BY REGIONS

4.1 Hospital Acquired Pneumonia Drugs by Regions
  4.1.1 Global Hospital Acquired Pneumonia Drugs Consumption by Regions
  4.1.2 Global Hospital Acquired Pneumonia Drugs Value by Regions
4.2 Americas Hospital Acquired Pneumonia Drugs Consumption Growth
4.3 APAC Hospital Acquired Pneumonia Drugs Consumption Growth
4.4 Europe Hospital Acquired Pneumonia Drugs Consumption Growth
4.5 Middle East & Africa Hospital Acquired Pneumonia Drugs Consumption Growth

5 AMERICAS

5.1 Americas Hospital Acquired Pneumonia Drugs Consumption by Countries
  5.1.1 Americas Hospital Acquired Pneumonia Drugs Consumption by Countries (2013-2018)
  5.1.2 Americas Hospital Acquired Pneumonia Drugs Value by Countries (2013-2018)
5.2 Americas Hospital Acquired Pneumonia Drugs Consumption by Type
5.3 Americas Hospital Acquired Pneumonia Drugs Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Hospital Acquired Pneumonia Drugs Consumption by Countries
  6.1.1 APAC Hospital Acquired Pneumonia Drugs Consumption by Countries (2013-2018)
  6.1.2 APAC Hospital Acquired Pneumonia Drugs Value by Countries (2013-2018)
6.2 APAC Hospital Acquired Pneumonia Drugs Consumption by Type
6.3 APAC Hospital Acquired Pneumonia Drugs Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Hospital Acquired Pneumonia Drugs by Countries
  7.1.1 Europe Hospital Acquired Pneumonia Drugs Consumption by Countries (2013-2018)
  7.1.2 Europe Hospital Acquired Pneumonia Drugs Value by Countries (2013-2018)
7.2 Europe Hospital Acquired Pneumonia Drugs Consumption by Type
7.3 Europe Hospital Acquired Pneumonia Drugs Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Hospital Acquired Pneumonia Drugs by Countries
  8.1.1 Middle East & Africa Hospital Acquired Pneumonia Drugs Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa Hospital Acquired Pneumonia Drugs Value by Countries (2013-2018)
8.2 Middle East & Africa Hospital Acquired Pneumonia Drugs Consumption by Type
8.3 Middle East & Africa Hospital Acquired Pneumonia Drugs Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 Hospital Acquired Pneumonia Drugs Distributors
10.3 Hospital Acquired Pneumonia Drugs Customer

11 GLOBAL HOSPITAL ACQUIRED PNEUMONIA DRUGS MARKET FORECAST

11.1 Global Hospital Acquired Pneumonia Drugs Consumption Forecast (2018-2023)
11.2 Global Hospital Acquired Pneumonia Drugs Forecast by Regions
  11.2.1 Global Hospital Acquired Pneumonia Drugs Forecast by Regions (2018-2023)
  11.2.2 Global Hospital Acquired Pneumonia Drugs Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Hospital Acquired Pneumonia Drugs Forecast by Type
11.8 Global Hospital Acquired Pneumonia Drugs Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 Basilea Pharmaceutica
  12.1.1 Company Details
  12.1.2 Hospital Acquired Pneumonia Drugs Product Offered
  12.1.3 Basilea Pharmaceutica Hospital Acquired Pneumonia Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 Basilea Pharmaceutica News
12.2 Meiji Holdings
  12.2.1 Company Details
  12.2.2 Hospital Acquired Pneumonia Drugs Product Offered
  12.2.3 Meiji Holdings Hospital Acquired Pneumonia Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 Meiji Holdings News
12.3 Cubist Pharmaceutical
  12.3.1 Company Details
  12.3.2 Hospital Acquired Pneumonia Drugs Product Offered
  12.3.3 Cubist Pharmaceutical Hospital Acquired Pneumonia Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 Cubist Pharmaceutical News
12.4 Aridis Pharmaceutical
  12.4.1 Company Details
  12.4.2 Hospital Acquired Pneumonia Drugs Product Offered
  12.4.3 Aridis Pharmaceutical Hospital Acquired Pneumonia Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 Aridis Pharmaceutical News
12.5 Valneva
  12.5.1 Company Details
  12.5.2 Hospital Acquired Pneumonia Drugs Product Offered
  12.5.3 Valneva Hospital Acquired Pneumonia Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.5.4 Main Business Overview
  12.5.5 Valneva News
12.6 Bayer
  12.6.1 Company Details
  12.6.2 Hospital Acquired Pneumonia Drugs Product Offered
  12.6.3 Bayer Hospital Acquired Pneumonia Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.6.4 Main Business Overview
  12.6.5 Bayer News
12.7 GlaxoSmithKline
  12.7.1 Company Details
  12.7.2 Hospital Acquired Pneumonia Drugs Product Offered
  12.7.3 GlaxoSmithKline Hospital Acquired Pneumonia Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.7.4 Main Business Overview
  12.7.5 GlaxoSmithKline News
12.8 Merck
  12.8.1 Company Details
  12.8.2 Hospital Acquired Pneumonia Drugs Product Offered
  12.8.3 Merck Hospital Acquired Pneumonia Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.8.4 Main Business Overview
  12.8.5 Merck News
12.9 Achaogen
  12.9.1 Company Details
  12.9.2 Hospital Acquired Pneumonia Drugs Product Offered
  12.9.3 Achaogen Hospital Acquired Pneumonia Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.9.4 Main Business Overview
  12.9.5 Achaogen News
12.10 AstraZeneca
  12.10.1 Company Details
  12.10.2 Hospital Acquired Pneumonia Drugs Product Offered
  12.10.3 AstraZeneca Hospital Acquired Pneumonia Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.10.4 Main Business Overview
  12.10.5 AstraZeneca News

13 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Hospital Acquired Pneumonia Drugs
Table Product Specifications of Hospital Acquired Pneumonia Drugs
Figure Hospital Acquired Pneumonia Drugs Report Years Considered
Figure Market Research Methodology
Figure Global Hospital Acquired Pneumonia Drugs Consumption Growth Rate 2013-2023 (Kg)
Figure Global Hospital Acquired Pneumonia Drugs Value Growth Rate 2013-2023 ($ Millions)
Table Hospital Acquired Pneumonia Drugs Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Phase II
Table Major Players of Phase II
Figure Product Picture of Early Phase (Phase I & II)
Table Major Players of Early Phase (Phase I & II)
Table Global Consumption Sales by Type (2013-2018)
Table Global Hospital Acquired Pneumonia Drugs Consumption Market Share by Type (2013-2018)
Figure Global Hospital Acquired Pneumonia Drugs Consumption Market Share by Type (2013-2018)
Table Global Hospital Acquired Pneumonia Drugs Revenue by Type (2013-2018) ($ million)
Table Global Hospital Acquired Pneumonia Drugs Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Hospital Acquired Pneumonia Drugs Value Market Share by Type (2013-2018)
Table Global Hospital Acquired Pneumonia Drugs Sale Price by Type (2013-2018)
Figure Hospital Acquired Pneumonia Drugs Consumed in Hospital Pharmacies
Figure Global Hospital Acquired Pneumonia Drugs Market: Hospital Pharmacies (2013-2018) (Kg)
Figure Global Hospital Acquired Pneumonia Drugs Market: Hospital Pharmacies (2013-2018) ($ Millions)
Figure Global Hospital Pharmacies YoY Growth ($ Millions)
Figure Hospital Acquired Pneumonia Drugs Consumed in Retail Pharmacies
Figure Global Hospital Acquired Pneumonia Drugs Market: Retail Pharmacies (2013-2018) (Kg)
Figure Global Hospital Acquired Pneumonia Drugs Market: Retail Pharmacies (2013-2018) ($ Millions)
Figure Global Retail Pharmacies YoY Growth ($ Millions)
Figure Hospital Acquired Pneumonia Drugs Consumed in Drug Store
Figure Global Hospital Acquired Pneumonia Drugs Market: Drug Store (2013-2018) (Kg)
Figure Global Hospital Acquired Pneumonia Drugs Market: Drug Store (2013-2018) ($ Millions)
Figure Global Drug Store YoY Growth ($ Millions)
Figure Hospital Acquired Pneumonia Drugs Consumed in E-Commerce
Figure Global Hospital Acquired Pneumonia Drugs Market: E-Commerce (2013-2018) (Kg)
Figure Global Hospital Acquired Pneumonia Drugs Market: E-Commerce (2013-2018) ($ Millions)
Figure Global E-Commerce YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Hospital Acquired Pneumonia Drugs Consumption Market Share by Application (2013-2018)
Figure Global Hospital Acquired Pneumonia Drugs Consumption Market Share by Application (2013-2018)
Table Global Hospital Acquired Pneumonia Drugs Value by Application (2013-2018)
Table Global Hospital Acquired Pneumonia Drugs Value Market Share by Application (2013-2018)
Figure Global Hospital Acquired Pneumonia Drugs Value Market Share by Application (2013-2018)
Table Global Hospital Acquired Pneumonia Drugs Sale Price by Application (2013-2018)
Table Global Hospital Acquired Pneumonia Drugs Sales by Players (2016-2018) (Kg)
Table Global Hospital Acquired Pneumonia Drugs Sales Market Share by Players (2016-2018)
Figure Global Hospital Acquired Pneumonia Drugs Sales Market Share by Players in 2016
Figure Global Hospital Acquired Pneumonia Drugs Sales Market Share by Players in 2017
Table Global Hospital Acquired Pneumonia Drugs Revenue by Players (2016-2018) ($ Millions)
Table Global Hospital Acquired Pneumonia Drugs Revenue Market Share by Players (2016-2018)
Figure Global Hospital Acquired Pneumonia Drugs Revenue Market Share by Players in 2016
Figure Global Hospital Acquired Pneumonia Drugs Revenue Market Share by Players in 2017
Table Global Hospital Acquired Pneumonia Drugs Sale Price by Players (2016-2018)
Figure Global Hospital Acquired Pneumonia Drugs Sale Price by Players in 2017
Table Global Hospital Acquired Pneumonia Drugs Manufacturing Base Distribution and Sales Area by Players
Table Players Hospital Acquired Pneumonia Drugs Products Offered
Table Hospital Acquired Pneumonia Drugs Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Hospital Acquired Pneumonia Drugs Consumption by Regions 2013-2018 (Kg)
Table Global Hospital Acquired Pneumonia Drugs Consumption Market Share by Regions 2013-2018
Figure Global Hospital Acquired Pneumonia Drugs Consumption Market Share by Regions 2013-2018
Table Global Hospital Acquired Pneumonia Drugs Value by Regions 2013-2018 ($ Millions)
Table Global Hospital Acquired Pneumonia Drugs Value Market Share by Regions 2013-2018
Figure Global Hospital Acquired Pneumonia Drugs Value Market Share by Regions 2013-2018
Figure Americas Hospital Acquired Pneumonia Drugs Consumption 2013-2018 (Kg)
Figure Americas Hospital Acquired Pneumonia Drugs Value 2013-2018 ($ Millions)
Figure APAC Hospital Acquired Pneumonia Drugs Consumption 2013-2018 (Kg)
Figure APAC Hospital Acquired Pneumonia Drugs Value 2013-2018 ($ Millions)
Figure Europe Hospital Acquired Pneumonia Drugs Consumption 2013-2018 (Kg)
Figure Europe Hospital Acquired Pneumonia Drugs Value 2013-2018 ($ Millions)
Figure Middle East & Africa Hospital Acquired Pneumonia Drugs Consumption 2013-2018 (Kg)
Figure Middle East & Africa Hospital Acquired Pneumonia Drugs Value 2013-2018 ($ Millions)
Table Americas Hospital Acquired Pneumonia Drugs Consumption by Countries (2013-2018) (Kg)
Table Americas Hospital Acquired Pneumonia Drugs Consumption Market Share by Countries (2013-2018)
Figure Americas Hospital Acquired Pneumonia Drugs Consumption Market Share by Countries in 2017
Table Americas Hospital Acquired Pneumonia Drugs Value by Countries (2013-2018) ($ Millions)
Table Americas Hospital Acquired Pneumonia Drugs Value Market Share by Countries (2013-2018)
Figure Americas Hospital Acquired Pneumonia Drugs Value Market Share by Countries in 2017
Table Americas Hospital Acquired Pneumonia Drugs Consumption by Type (2013-2018) (Kg)
Table Americas Hospital Acquired Pneumonia Drugs Consumption Market Share by Type (2013-2018)
Figure Americas Hospital Acquired Pneumonia Drugs Consumption Market Share by Type in 2017
Table Americas Hospital Acquired Pneumonia Drugs Consumption by Application (2013-2018) (Kg)
Table Americas Hospital Acquired Pneumonia Drugs Consumption Market Share by Application (2013-2018)
Figure Americas Hospital Acquired Pneumonia Drugs Consumption Market Share by Application in 2017
Figure United States Hospital Acquired Pneumonia Drugs Consumption Growth 2013-2018 (Kg)
Figure United States Hospital Acquired Pneumonia Drugs Value Growth 2013-2018 ($ Millions)
Figure Canada Hospital Acquired Pneumonia Drugs Consumption Growth 2013-2018 (Kg)
Figure Canada Hospital Acquired Pneumonia Drugs Value Growth 2013-2018 ($ Millions)
Figure Mexico Hospital Acquired Pneumonia Drugs Consumption Growth 2013-2018 (Kg)
Figure Mexico Hospital Acquired Pneumonia Drugs Value Growth 2013-2018 ($ Millions)
Table APAC Hospital Acquired Pneumonia Drugs Consumption by Countries (2013-2018) (Kg)
Table APAC Hospital Acquired Pneumonia Drugs Consumption Market Share by Countries (2013-2018)
Figure APAC Hospital Acquired Pneumonia Drugs Consumption Market Share by Countries in 2017
Table APAC Hospital Acquired Pneumonia Drugs Value by Countries (2013-2018) ($ Millions)
Table APAC Hospital Acquired Pneumonia Drugs Value Market Share by Countries (2013-2018)
Figure APAC Hospital Acquired Pneumonia Drugs Value Market Share by Countries in 2017
Table APAC Hospital Acquired Pneumonia Drugs Consumption by Type (2013-2018) (Kg)
Table APAC Hospital Acquired Pneumonia Drugs Consumption Market Share by Type (2013-2018)
Figure APAC Hospital Acquired Pneumonia Drugs Consumption Market Share by Type in 2017
Table APAC Hospital Acquired Pneumonia Drugs Consumption by Application (2013-2018) (Kg)
Table APAC Hospital Acquired Pneumonia Drugs Consumption Market Share by Application (2013-2018)
Figure APAC Hospital Acquired Pneumonia Drugs Consumption Market Share by Application in 2017
Figure China Hospital Acquired Pneumonia Drugs Consumption Growth 2013-2018 (Kg)
Figure China Hospital Acquired Pneumonia Drugs Value Growth 2013-2018 ($ Millions)
Figure Japan Hospital Acquired Pneumonia Drugs Consumption Growth 2013-2018 (Kg)
Figure Japan Hospital Acquired Pneumonia Drugs Value Growth 2013-2018 ($ Millions)
Figure Korea Hospital Acquired Pneumonia Drugs Consumption Growth 2013-2018 (Kg)
Figure Korea Hospital Acquired Pneumonia Drugs Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Hospital Acquired Pneumonia Drugs Consumption Growth 2013-2018 (Kg)
Figure Southeast Asia Hospital Acquired Pneumonia Drugs Value Growth 2013-2018 ($ Millions)
Figure India Hospital Acquired Pneumonia Drugs Consumption Growth 2013-2018 (Kg)
Figure India Hospital Acquired Pneumonia Drugs Value Growth 2013-2018 ($ Millions)
Figure Australia Hospital Acquired Pneumonia Drugs Consumption Growth 2013-2018 (Kg)
Figure Australia Hospital Acquired Pneumonia Drugs Value Growth 2013-2018 ($ Millions)
Table Europe Hospital Acquired Pneumonia Drugs Consumption by Countries (2013-2018) (Kg)
Table Europe Hospital Acquired Pneumonia Drugs Consumption Market Share by Countries (2013-2018)
Figure Europe Hospital Acquired Pneumonia Drugs Consumption Market Share by Countries in 2017
Table Europe Hospital Acquired Pneumonia Drugs Value by Countries (2013-2018) ($ Millions)
Table Europe Hospital Acquired Pneumonia Drugs Value Market Share by Countries (2013-2018)
Figure Europe Hospital Acquired Pneumonia Drugs Value Market Share by Countries in 2017
Table Europe Hospital Acquired Pneumonia Drugs Consumption by Type (2013-2018) (Kg)
Table Europe Hospital Acquired Pneumonia Drugs Consumption Market Share by Type (2013-2018)
Figure Europe Hospital Acquired Pneumonia Drugs Consumption Market Share by Type in 2017
Table Europe Hospital Acquired Pneumonia Drugs Consumption by Application (2013-2018) (Kg)
Table Europe Hospital Acquired Pneumonia Drugs Consumption Market Share by Application (2013-2018)
Figure Europe Hospital Acquired Pneumonia Drugs Consumption Market Share by Application in 2017
Figure Germany Hospital Acquired Pneumonia Drugs Consumption Growth 2013-2018 (Kg)
Figure Germany Hospital Acquired Pneumonia Drugs Value Growth 2013-2018 ($ Millions)
Figure France Hospital Acquired Pneumonia Drugs Consumption Growth 2013-2018 (Kg)
Figure France Hospital Acquired Pneumonia Drugs Value Growth 2013-2018 ($ Millions)
Figure UK Hospital Acquired Pneumonia Drugs Consumption Growth 2013-2018 (Kg)
Figure UK Hospital Acquired Pneumonia Drugs Value Growth 2013-2018 ($ Millions)
Figure Italy Hospital Acquired Pneumonia Drugs Consumption Growth 2013-2018 (Kg)
Figure Italy Hospital Acquired Pneumonia Drugs Value Growth 2013-2018 ($ Millions)
Figure Russia Hospital Acquired Pneumonia Drugs Consumption Growth 2013-2018 (Kg)
Figure Russia Hospital Acquired Pneumonia Drugs Value Growth 2013-2018 ($ Millions)
Figure Spain Hospital Acquired Pneumonia Drugs Consumption Growth 2013-2018 (Kg)
Figure Spain Hospital Acquired Pneumonia Drugs Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Hospital Acquired Pneumonia Drugs Consumption by Countries (2013-2018) (Kg)
Table Middle East & Africa Hospital Acquired Pneumonia Drugs Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Hospital Acquired Pneumonia Drugs Consumption Market Share by Countries in 2017
Table Middle East & Africa Hospital Acquired Pneumonia Drugs Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Hospital Acquired Pneumonia Drugs Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Hospital Acquired Pneumonia Drugs Value Market Share by Countries in 2017
Table Middle East & Africa Hospital Acquired Pneumonia Drugs Consumption by Type (2013-2018) (Kg)
Table Middle East & Africa Hospital Acquired Pneumonia Drugs Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Hospital Acquired Pneumonia Drugs Consumption Market Share by Type in 2017
Table Middle East & Africa Hospital Acquired Pneumonia Drugs Consumption by Application (2013-2018) (Kg)
Table Middle East & Africa Hospital Acquired Pneumonia Drugs Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Hospital Acquired Pneumonia Drugs Consumption Market Share by Application in 2017
Figure Egypt Hospital Acquired Pneumonia Drugs Consumption Growth 2013-2018 (Kg)
Figure Egypt Hospital Acquired Pneumonia Drugs Value Growth 2013-2018 ($ Millions)
Figure South Africa Hospital Acquired Pneumonia Drugs Consumption Growth 2013-2018 (Kg)
Figure South Africa Hospital Acquired Pneumonia Drugs Value Growth 2013-2018 ($ Millions)
Figure Israel Hospital Acquired Pneumonia Drugs Consumption Growth 2013-2018 (Kg)
Figure Israel Hospital Acquired Pneumonia Drugs Value Growth 2013-2018 ($ Millions)
Figure Turkey Hospital Acquired Pneumonia Drugs Consumption Growth 2013-2018 (Kg)
Figure Turkey Hospital Acquired Pneumonia Drugs Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Hospital Acquired Pneumonia Drugs Consumption Growth 2013-2018 (Kg)
Figure GCC Countries Hospital Acquired Pneumonia Drugs Value Growth 2013-2018 ($ Millions)
Table Hospital Acquired Pneumonia Drugs Distributors List
Table Hospital Acquired Pneumonia Drugs Customer List
Figure Global Hospital Acquired Pneumonia Drugs Consumption Growth Rate Forecast (2018-2023) (Kg)
Figure Global Hospital Acquired Pneumonia Drugs Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Hospital Acquired Pneumonia Drugs Consumption Forecast by Countries (2018-2023) (Kg)
Table Global Hospital Acquired Pneumonia Drugs Consumption Market Forecast by Regions
Table Global Hospital Acquired Pneumonia Drugs Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Hospital Acquired Pneumonia Drugs Value Market Share Forecast by Regions
Figure Americas Hospital Acquired Pneumonia Drugs Consumption 2018-2023 (Kg)
Figure Americas Hospital Acquired Pneumonia Drugs Value 2018-2023 ($ Millions)
Figure APAC Hospital Acquired Pneumonia Drugs Consumption 2018-2023 (Kg)
Figure APAC Hospital Acquired Pneumonia Drugs Value 2018-2023 ($ Millions)
Figure Europe Hospital Acquired Pneumonia Drugs Consumption 2018-2023 (Kg)
Figure Europe Hospital Acquired Pneumonia Drugs Value 2018-2023 ($ Millions)
Figure Middle East & Africa Hospital Acquired Pneumonia Drugs Consumption 2018-2023 (Kg)
Figure Middle East & Africa Hospital Acquired Pneumonia Drugs Value 2018-2023 ($ Millions)
Figure United States Hospital Acquired Pneumonia Drugs Consumption 2018-2023 (Kg)
Figure United States Hospital Acquired Pneumonia Drugs Value 2018-2023 ($ Millions)
Figure Canada Hospital Acquired Pneumonia Drugs Consumption 2018-2023 (Kg)
Figure Canada Hospital Acquired Pneumonia Drugs Value 2018-2023 ($ Millions)
Figure Mexico Hospital Acquired Pneumonia Drugs Consumption 2018-2023 (Kg)
Figure Mexico Hospital Acquired Pneumonia Drugs Value 2018-2023 ($ Millions)
Figure Brazil Hospital Acquired Pneumonia Drugs Consumption 2018-2023 (Kg)
Figure Brazil Hospital Acquired Pneumonia Drugs Value 2018-2023 ($ Millions)
Figure China Hospital Acquired Pneumonia Drugs Consumption 2018-2023 (Kg)
Figure China Hospital Acquired Pneumonia Drugs Value 2018-2023 ($ Millions)
Figure Japan Hospital Acquired Pneumonia Drugs Consumption 2018-2023 (Kg)
Figure Japan Hospital Acquired Pneumonia Drugs Value 2018-2023 ($ Millions)
Figure Korea Hospital Acquired Pneumonia Drugs Consumption 2018-2023 (Kg)
Figure Korea Hospital Acquired Pneumonia Drugs Value 2018-2023 ($ Millions)
Figure Southeast Asia Hospital Acquired Pneumonia Drugs Consumption 2018-2023 (Kg)
Figure Southeast Asia Hospital Acquired Pneumonia Drugs Value 2018-2023 ($ Millions)
Figure India Hospital Acquired Pneumonia Drugs Consumption 2018-2023 (Kg)
Figure India Hospital Acquired Pneumonia Drugs Value 2018-2023 ($ Millions)
Figure Australia Hospital Acquired Pneumonia Drugs Consumption 2018-2023 (Kg)
Figure Australia Hospital Acquired Pneumonia Drugs Value 2018-2023 ($ Millions)
Figure Germany Hospital Acquired Pneumonia Drugs Consumption 2018-2023 (Kg)
Figure Germany Hospital Acquired Pneumonia Drugs Value 2018-2023 ($ Millions)
Figure France Hospital Acquired Pneumonia Drugs Consumption 2018-2023 (Kg)
Figure France Hospital Acquired Pneumonia Drugs Value 2018-2023 ($ Millions)
Figure UK Hospital Acquired Pneumonia Drugs Consumption 2018-2023 (Kg)
Figure UK Hospital Acquired Pneumonia Drugs Value 2018-2023 ($ Millions)
Figure Italy Hospital Acquired Pneumonia Drugs Consumption 2018-2023 (Kg)
Figure Italy Hospital Acquired Pneumonia Drugs Value 2018-2023 ($ Millions)
Figure Russia Hospital Acquired Pneumonia Drugs Consumption 2018-2023 (Kg)
Figure Russia Hospital Acquired Pneumonia Drugs Value 2018-2023 ($ Millions)
Figure Spain Hospital Acquired Pneumonia Drugs Consumption 2018-2023 (Kg)
Figure Spain Hospital Acquired Pneumonia Drugs Value 2018-2023 ($ Millions)
Figure Egypt Hospital Acquired Pneumonia Drugs Consumption 2018-2023 (Kg)
Figure Egypt Hospital Acquired Pneumonia Drugs Value 2018-2023 ($ Millions)
Figure South Africa Hospital Acquired Pneumonia Drugs Consumption 2018-2023 (Kg)
Figure South Africa Hospital Acquired Pneumonia Drugs Value 2018-2023 ($ Millions)
Figure Israel Hospital Acquired Pneumonia Drugs Consumption 2018-2023 (Kg)
Figure Israel Hospital Acquired Pneumonia Drugs Value 2018-2023 ($ Millions)
Figure Turkey Hospital Acquired Pneumonia Drugs Consumption 2018-2023 (Kg)
Figure Turkey Hospital Acquired Pneumonia Drugs Value 2018-2023 ($ Millions)
Figure GCC Countries Hospital Acquired Pneumonia Drugs Consumption 2018-2023 (Kg)
Figure GCC Countries Hospital Acquired Pneumonia Drugs Value 2018-2023 ($ Millions)
Table Global Hospital Acquired Pneumonia Drugs Consumption Forecast by Type (2018-2023) (Kg)
Table Global Hospital Acquired Pneumonia Drugs Consumption Market Share Forecast by Type (2018-2023)
Table Global Hospital Acquired Pneumonia Drugs Value Forecast by Type (2018-2023) ($ Millions)
Table Global Hospital Acquired Pneumonia Drugs Value Market Share Forecast by Type (2018-2023)
Table Global Hospital Acquired Pneumonia Drugs Consumption Forecast by Application (2018-2023) (Kg)
Table Global Hospital Acquired Pneumonia Drugs Consumption Market Share Forecast by Application (2018-2023)
Table Global Hospital Acquired Pneumonia Drugs Value Forecast by Application (2018-2023) ($ Millions)
Table Global Hospital Acquired Pneumonia Drugs Value Market Share Forecast by Application (2018-2023)
Table Basilea Pharmaceutica Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Basilea Pharmaceutica Hospital Acquired Pneumonia Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Basilea Pharmaceutica Hospital Acquired Pneumonia Drugs Market Share (2016-2018)
Table Meiji Holdings Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Meiji Holdings Hospital Acquired Pneumonia Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Meiji Holdings Hospital Acquired Pneumonia Drugs Market Share (2016-2018)
Table Cubist Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Cubist Pharmaceutical Hospital Acquired Pneumonia Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Cubist Pharmaceutical Hospital Acquired Pneumonia Drugs Market Share (2016-2018)
Table Aridis Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Aridis Pharmaceutical Hospital Acquired Pneumonia Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Aridis Pharmaceutical Hospital Acquired Pneumonia Drugs Market Share (2016-2018)
Table Valneva Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Valneva Hospital Acquired Pneumonia Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Valneva Hospital Acquired Pneumonia Drugs Market Share (2016-2018)
Table Bayer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer Hospital Acquired Pneumonia Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Bayer Hospital Acquired Pneumonia Drugs Market Share (2016-2018)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Hospital Acquired Pneumonia Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure GlaxoSmithKline Hospital Acquired Pneumonia Drugs Market Share (2016-2018)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Hospital Acquired Pneumonia Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Merck Hospital Acquired Pneumonia Drugs Market Share (2016-2018)
Table Achaogen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Achaogen Hospital Acquired Pneumonia Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Achaogen Hospital Acquired Pneumonia Drugs Market Share (2016-2018)
Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AstraZeneca Hospital Acquired Pneumonia Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure AstraZeneca Hospital Acquired Pneumonia Drugs Market Share (2016-2018)